[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
October 6, 1962

Negative Results

JAMA. 1962;182(1):67. doi:10.1001/jama.1962.03050400069012
Abstract

Mebutamate as an Antihypertensive Agent  J. Marion Bryant, M.D., New York CityMEBUTAMATE (Capla), an analog of meprobamate (Miltown, Equanil) with an additional methyl group on the propyl side chain, has been reported to have antihypertensive properties.1-5 Blood pressure observations during mebutamate administration, with and without hydrochlorothiazide (Esidrix, Hydro Diuril), in a group of ambulatory subjects with long-standing essential hypertension are presented in this paper.

Material and Methods  Thirty-three patients (9 male and 24 female), 38 to 72 years of age (mean 59 ± 9), with hypertension of 1 to 26 years duration ( mean 9 ±7 ) were studied.Four control, nonrested, blood-pressure observations, in both recumbent and standing positions, were recorded. The means of these values are used in this report. Those designated "original" control were obtained at the first clinic visit, the "final" control at the end of placebo periods of 4 to 60 weeks (mean 16 ± 12),

References
1.
Berger, F. M., and Margolin, S.:  Central Acting Blood Pressure Lowering Agent (W-583) ,  Fed Proc 20:113 ( (March) ) 1961.
2.
Mulinos, M. F., et al.:  Human Pharmacology Studies with W-583 ,  Fed Proc 20:113 ( (March) ) 1961.
3.
Duarte, C., et al.:  Observations on Antihypertensive Effectiveness of New Propanediol Dicarbamate (W-583) ,  Curr Ther Res 2:148-152 ( (May) ) 1960.
4.
Holloman, J.L.S., Jr.:  Treatment of Hypertensive Patients with Mebutamate, New Antihypertensive Drug: Preliminary Study ,  JAMA 54:94-98 ( (Jan.) ) 1962.
5.
Bohensky, F. D.:  Mebutamate, New Drug for Treatment of Hypertension ,  New York J Med 62:841-846 ( (March 15) ) 1962.
×